Exploring the antimicrobial potential of streptococcal fratricins
Abstract
Many streptococci are competent for natural transformation, during which they express a murein hydrolase that lyses and kills closely related species, thereby making homologous DNA available for uptake by competent cells. This process, termed fratricide, is mediated by enzymes known as fratricins. The most extensively studied fratricin, CbpD from Streptococcus pneumoniae, is highly specific, efficient, and rapid in its killing, highlighting the potential of fratricins as targeted antimicrobial agents. Here, we screened nine putative fratricins to evaluate their antimicrobial activity. Of these, Zoocin A from Streptococcus agalactiae, ScrM from Streptococcus dysgalactiae, and CbpD from Streptococcus vestibularis were successfully purified. Zoocin A exhibited the broadest target range, whereas ScrM and CbpD-ves showed somewhat narrower activity. All three enzymes predominantly targeted streptococci. Notably, Zoocin A was active against Streptococcus mutans and Streptococcus sobrinus, species associated with dental caries. The enzymes were also active against S. agalactiae, S. dysgalactiae, and S. pyogenes, which are associated with severe infections in humans and animals. We characterised the activity and stability of Zoocin A and ScrM and found that both retained activity under physiologically relevant conditions of pH, temperature, and ionic strength. ScrM activity was independent of divalent cations, whereas Zoocin A activity required cations and was observed with both Ca2+ and Mn2+. For both enzymes, peptidoglycan cleavage was localised to the septal region of dividing cells. Zoocin A shows promise as an antimicrobial agent against S. mutans, but its efficacy against biofilms would likely benefit from further optimisation or combination with biofilm-disrupting agents. Importance Streptococci are major pathogens of humans and animals, causing infections ranging from common mucosal and dental diseases to severe invasive and systemic infections. The increasing prevalence of antimicrobial resistance among clinically important streptococci is a major challenge to healthcare systems who are running out of treatment options. It is therefore necessary to develop new approaches to prevent and treat streptococcal infections. Fratricins are streptococcal peptidoglycan hydrolases that mediate killing of closely related bacteria during natural competence, suggesting that they could be harnessed as targeted antimicrobials against pathogenic streptococci. However, the diversity and antimicrobial potential of fratricins remain poorly explored. By identifying and characterising putative fratricins, this work contributes to expanding the repertoire of antimicrobials and provides a foundation for developing fratricin-based approaches to combat streptococcal infections.